Databricks, a data software company, plans to sell shares to the public at some point, but won’t tap the public markets this year amid a flurry of planned tech IPOs. The company wants to sell shares ...

Investment deepens alignment between Databricks and v4c as the company joins an exclusive portfolio of ecosystem leaders following breakout momentum v4c.ai, a strategic boutique pure-play Databricks ...

Arsalan Tavakoli was at his bachelor party in 2013 when Ali Ghodsi, a computer science researcher at the University of California, Berkeley, pulled him aside. The two had become colleagues and friends ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

Director Destin Daniel Cretton, stars Tom Holland and Zendaya, and crew members offer an annotated script from the Sony/Marvel release.

Full 12-row table, all 48 per-scale rows, and an interactive chart per scenario live in results/results.md and results/results.html.

When Lyria 3 launched last month, Gemini could generate 30-second audio clips from prompts. With the new advanced model, the chatbot can now create tracks up to 3 minutes long and follow instructions ...

With an overflowing war chest from its $5 billion raise that closed last month (not to mention billions in revenue), Databricks is acquiring. The company, best known for its cloud data analytics ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...